REGENERIS MEDICAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease
Phase 1
Not yet recruiting
- Conditions
- Cyotokine StormCovid-19 Pneumonia
- Interventions
- Biological: Autologous Adipose MSC's
- First Posted Date
- 2020-04-20
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- Regeneris Medical
- Target Recruit Count
- 20
- Registration Number
- NCT04352803
Autologous Stem/Stromal Cells in Neurological Disorders and Disease
Not Applicable
- Conditions
- DementiaAltered Behavior in Alzheimer DiseaseCorticobasal DegenerationParkinsonDemyelinating Autoimmune Diseases, CNSDemyelinating Sensorimotor Neuropathy
- Interventions
- Procedure: Microcannula Harvest AdiposeDevice: Centricyte 1000Procedure: Sterile Normal Saline Infusion
- First Posted Date
- 2017-09-29
- Last Posted Date
- 2018-10-18
- Lead Sponsor
- Regeneris Medical
- Target Recruit Count
- 300
- Registration Number
- NCT03297177
- Locations
- 🇺🇸
Regeneris Medical Inc, North Attleboro, Massachusetts, United States
🇺🇸Regeneris Medical, North Attleboro, Massachusetts, United States
Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata
Not Applicable
Recruiting
- Conditions
- Alopecia AreataScarring Alopecia
- Interventions
- Procedure: tSVF by lipoaspirationProcedure: PRP ConcentrationProcedure: Emulsification tSVFProcedure: cSVF in Normal Saline IVProcedure: cSVF isolation and concentration
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2020-04-16
- Lead Sponsor
- Regeneris Medical
- Target Recruit Count
- 60
- Registration Number
- NCT03078686
- Locations
- 🇺🇸
Regeneris Medical, North Attleboro, Massachusetts, United States
🇺🇸Regenevita LLC, Stevensville, Montana, United States
🇺🇸Kenneth Williams, DO, Irvine, California, United States
© Copyright 2025. All Rights Reserved by MedPath